Yi-Zhuo Zhang
Overview
Explore the profile of Yi-Zhuo Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
126
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Wang X, Wang C, Xu W, Yang H, Zhao H, Wang X, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
. 2019 Feb;
27(1):52-60.
PMID: 30738447
Objective: To compare the prognostic value of different staging systems in primary intestinal diffuse large B cell lymphoma（PI-DLPCL）, and their correlation with clinicopathological characteristics，treatment and prognosis of PI-DLBCL. Methods: A...
12.
Wang X, Xia B, Zhang Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi
. 2018 Dec;
26(6):1841-1846.
PMID: 30501731
Diffuse large B cell lymphoma（DLBCL）is the most common non-Hodgkin's lymphoma in adults，accounting for 30%-40% of non-Hodgkin's lymphoma in adults. The treatments of this lymphoma mainly include chemotherapy，radiotherapy and autologous hematopoietic...
13.
Xu Y, Xia B, Wang L, Wang C, Zhao H, Yang H, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
. 2018 Dec;
26(6):1668-1674.
PMID: 30501702
Objective: To evaluate the therapeutic effect and adverse reactions of the maintenance therapies with Thalidomine or Bortezomib in the patients with newly diagnosed multiple myeloma (MM), so as to provide...
14.
Wang C, Xia B, Ning Q, Tian C, Zhao H, Yang H, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
. 2018 Oct;
26(5):1396-1402.
PMID: 30295257
Objective: To evaluate the therapeutic efficacy and prognosis of autologous stem Hematopoietic cell transplantation (auto-HSCT) in multiple myeloma (MM) patients. Methods: A retrospective study was conducted for 56 patients diagnosed...
15.
Wang Y, Xia B, Zhang Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi
. 2018 Apr;
26(2):603-608.
PMID: 29665940
Diffuse large B-cell lymphoma (DLBCL) is biologically aggressive and most common pathological type of non-Hodgkin's lymphoma (NHL), and about one-third of these patients are refractory or relapsed ultimately. Based on...
16.
Wang C, Tian C, Zhang Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi
. 2017 Aug;
25(4):1232-1236.
PMID: 28823299
The pathogenesis of diffuse large B-cell lymphoma(DLBCL) has not been fully elucidated, but people realized that the occurrence of DLBCL is caused by the mutual change of genetics and epigenetics...
17.
Wu L, Tian C, Zhang Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi
. 2017 Apr;
25(2):600-603.
PMID: 28446319
Splenic marginal zone lymphoma (SMZL) is an uncommon indolent B-cell non-Hodgkin's lymphoma. The clinical features of SMZL are splenomegaly, lymphocytosis and cytopenia in peripheral blood. Immunopheno-typically, the neoplastic cells are...
18.
Wang L, Yan B, Yu Y, Wang Y, Yang H, Zhao H, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
. 2017 Mar;
25(1):126-132.
PMID: 28245388
Background: A survey of early stage follicular lymphoma(FL) revealed that the rigorously staged FL patients at first diagnosis had a better outcome as compared with non-rigorous staged FL patients, but...
19.
Zhong Y, Zhang Y, Liao A, Li S, Tian C, Lu J
Chin Med J (Engl)
. 2017 Jan;
130(2):130-134.
PMID: 28091402
Background: Elderly multiple myeloma (MM) patients often tend to suffer a variety of diseases, so the treatment of choice is very difficult for the elderly myeloma patients. The overall survival...
20.
Wang L, Zhang Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi
. 2016 Jun;
24(3):945-8.
PMID: 27342539
Multiple myeloma (MM) is a malignancy of terminally differentiated monoclonal B cells, which is characterized by the presentation of malignant plasma cell within the bone marrow and the secretion of...